Bethan Charles
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
- Intracerebral and Subarachnoid Hemorrhage Research
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 5
-
- Antibiotic Use and Resistance 2
- Journals
- The Lancet (8 papers)JAMA (6 papers)Nature (4 papers)The Lancet Neurology (1 paper)Journal of Medical Microbiology (1 paper)
- Partner nations
- United KingdomAustraliaVietnam
In The Last Decade
Bethan Charles
23 papers receiving 3.8k citations
Bethan Charles's Hit Papers
Peers
Comparison fields: 5 of 123
- Infectious Diseases 1.7k
- Neurology 796
- Applied Microbiology and Biotechnology 89
- Critical Care and Intensive Care Medicine 186
- Internal Medicine 104
Countries citing papers authored by Bethan Charles
This map shows the geographic impact of Bethan Charles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bethan Charles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bethan Charles more than expected).
Fields of papers citing papers by Bethan Charles
This network shows the impact of papers produced by Bethan Charles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bethan Charles. The network helps show where Bethan Charles may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 Hit paper breakdown → | 2022 | 250 |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 7 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 228 |
| 8 | 2018 | 214 | |
| 9 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 10 | 2021 | 163 | |
| 11 | 2019 | 145 | |
| 12 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 13 | 2022 | 104 | |
| 14 | 2022 | 99 | |
| 15 | 2021 | 96 | |
| 16 | 2023 | 83 | |
| 17 | 2019 | 71 | |
| 18 | 2023 | 56 | |
| 19 | 2023 | 45 | |
| 20 | 2023 | 34 |
About Bethan Charles
Bethan Charles is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Neurology, Immunology and Epidemiology, having authored 23 papers that have together received 3.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), interferon and immune responses (3 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers), Pneumonia and Respiratory Infections (2 papers), Antibiotic Use and Resistance (2 papers), Respiratory viral infections research (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Infectious Diseases (1.7k citations), Neurology (796 citations), Applied Microbiology and Biotechnology (89 citations), Critical Care and Intensive Care Medicine (186 citations) and Internal Medicine (104 citations). Bethan Charles has collaborated with scholars based in United Kingdom, Australia and Vietnam. Their work appears in journals such as The Lancet, JAMA, Nature, The Lancet Neurology and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.